A important advancement in diabetes management is emerging with the approval of tirzepatide at a dosage of 45mg. This new formulation builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, and https://esocialmall.com/story6795671/groundbreaking-approach-tirzepatide-dose-for-glucose-control